Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja UBC Medical Indonesia Tbk. (LABS) vs Satu Visi Putra Tbk. (VISI)

UBC Medical Indonesia Tbk.Trading
Satu Visi Putra Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan UBC Medical Indonesia Tbk. dan Satu Visi Putra Tbk.: UBC Medical Indonesia Tbk. diperdagangkan di Rp148 (kapitalisasi pasar 576,7 M, volume 24 jam 3,48 jt), sedangkan Satu Visi Putra Tbk. diperdagangkan di Rp900 (kapitalisasi pasar 2,83 T, volume 24 jam 243,9 rb). Perbedaan utamanya: Satu Visi Putra Tbk. jauh lebih besar — sekitar 4,9× kapitalisasi pasar UBC Medical Indonesia Tbk., dan UBC Medical Indonesia Tbk. lebih aktif diperdagangkan (3,48 jt vs 243,9 rb). Mana yang lebih baik tergantung tujuan investasimu.

LABSVISI
Kapitalisasi Pasar
576,7 M2,83 T
Volume
3,48 jt243,9 rb
Lot
34,82 rb2,44 rb
Perputaran
522,79 jt223,04 jt
Harga Rata-rata
150,13914,47
Nilai Transaksi
522,79 jt223,04 jt
Harga Ekuilibrium Indikatif
148900
Volume Ekuilibrium Indikatif
3509

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

LABS
Lihat detail
VISI
Lihat detail

Tentang UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Selengkapnya di halaman LABS

Tentang Satu Visi Putra Tbk.

PT Satu Visi Putra Tbk (the Entity) was established based on Deed No. 16, dated February 14, 2018 of Soeprayitno, S.H., notary in Surabaya. The Entity started its commercial operation in 2018.

Selengkapnya di halaman VISI